However, CD44 expression apparently decreased within bladder urothelial carcinoma (BLCA), lung adenocarcinoma (LUAD), prostate adenocarcinoma (PRAD), and uterine corpus endometrial carcinoma (UCEC) tissues (Figure 1C). The gene discussed is CD44; the disease is prostate adenocarcinoma.